miR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin

Gene

Volumn 576, Issue 2, 2016, Pages 828-833

  Zhao, Jing ^a   Nie, Yuqiang ^a   Wang, Hong ^a   Lin, Yong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

ATG5; Autophagy; Drug resistance; Gastric cancer; miR 181a

Indexed keywords

AUTOPHAGY RELATED PROTEIN 5; CISPLATIN; MESSENGER RNA; MICRORNA; MICRORNA 181A; UNCLASSIFIED DRUG; ATG5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MIRN181 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER RESISTANCE; CELL VACUOLE; CONTROLLED STUDY; CYTOSOL; FEMALE; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; STOMACH CANCER; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; AUTOPHAGY; BASE SEQUENCE; CELL LINE, TUMOR; CISPLATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, NUDE; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; STOMACH NEOPLASMS;

EID: 84973421528     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.11.013     Document Type: Article

References (30)

1. An, Y., Zhang, Z., Shang, Y., Jiang, X., Dong, J., Yu, P., Nie, Y., Zhao, Q., miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis., 6, 2015, e1766.
2. Betel, D., Wilson, M., Gabow, A., Marks, D.S., Sander, C., The microRNA.org resource: targets and expression. Nucleic Acids Res. 36 (2008), D149–D153.
3. Brodersen, P., Voinnet, O., Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev. Mol. Cell Biol. 10 (2009), 141–148.
4. Burris, H.A. III, Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer Chemother. Pharmacol. 71 (2013), 829–842.
5. Chang, Z., Huo, L., Li, K., Wu, Y., Hu, Z., Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro. ScientificWorldJournal, 2014, 2014, 794756.
6. Cooke, C.L., Torres, J., Solnick, J.V., Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes 4 (2013), 532–540.
7. Das, G., Shravage, B.V., Baehrecke, E.H., Regulation and function of autophagy during cell survival and cell death. Cold Spring Harb. Perspect. Biol., 2012, 4.
8. Dicken, B.J., Bigam, D.L., Cass, C., Mackey, J.R., Joy, A.A., Hamilton, S.M., Gastric adenocarcinoma: review and considerations for future directions. Ann. Surg. 241 (2005), 27–39.
9. Guo, X.L., Li, D., Hu, F., Song, J.R., Zhang, S.S., Deng, W.J., Sun, K., Zhao, Q.D., Xie, X.Q., Song, Y.J., Wu, M.C., Wei, L.X., Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett. 320 (2012), 171–179.
10. Janku, F., McConkey, D.J., Hong, D.S., Kurzrock, R., Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol. 8 (2011), 528–539.
11. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., Segal, E., The role of site accessibility in microRNA target recognition. Nat. Genet. 39 (2007), 1278–1284.
12. Kim, J., Jeong, D., Nam, J., Aung, T.N., Gim, J.A., Park, K.U., Kim, S.W., MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma. Gene 558 (2015), 173–180.
13. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M., Rajewsky, N., Combinatorial microRNA target predictions. Nat. Genet. 37 (2005), 495–500.
14. Kumar, A., Singh, U.K., Chaudhary, A., Targeting autophagy to overcome drug resistance in cancer therapy. Future Med. Chem. 7 (2015), 1535–1542.
15. Kuo, Y.Z., Tai, Y.H., Lo, H.I., Chen, Y.L., Cheng, H.C., Fang, W.Y., Lin, S.H., Yang, C.L., Tsai, S.T., Wu, L.W., MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. Oral Dis. 20 (2014), e65–e75.
16. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., Burge, C.B., Prediction of mammalian microRNA targets. Cell 115 (2003), 787–798.
17. Li, S., Wang, L., Hu, Y., Sheng, R., Autophagy regulators as potential cancer therapeutic agents: a review. Curr. Top. Med. Chem. 15 (2015), 720–744.
18. Lin, Y., Nie, Y., Zhao, J., Chen, X., Ye, M., Li, Y., Du, Y., Cao, J., Shen, B., Li, Y., Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. Carcinogenesis 33 (2012), 2377–2383.
19. Liu, D., Yang, Y., Liu, Q., Wang, J., Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med. Oncol. 28 (2011), 105–111.
20. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta Delta C(T)) method. Methods 25 (2001), 402–408.
21. Manvati, S., Mangalhara, K.C., Kalaiarasan, P., Srivastava, N., Bamezai, R.N., miR-24-2 regulates genes in survival pathway and demonstrates potential in reducing cellular viability in combination with docetaxel. Gene 567 (2015), 217–224.
22. Mathew, R., Karantza-Wadsworth, V., White, E., Role of autophagy in cancer. Nat. Rev. Cancer 7 (2007), 961–967.
23. Miller, B.C., Zhao, Z., Stephenson, L.M., Cadwell, K., Pua, H.H., Lee, H.K., Mizushima, N.N., Iwasaki, A., He, Y.W., Swat, W. and Virgin, H.W.t., 2008. The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 4, 309–14.
24. Tekirdag, K.A., Korkmaz, G., Ozturk, D.G., Agami, R., Gozuacik, D., MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5. Autophagy 9 (2013), 374–385.
25. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J. Clin. 65 (2015), 87–108.
26. White, E., Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12 (2012), 401–410.
27. Xu, L., Beckebaum, S., Iacob, S., Wu, G., Kaiser, G.M., Radtke, A., Liu, C., Kabar, I., Schmidt, H.H., Zhang, X., Lu, M., Cicinnati, V.R., MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. J. Hepatol. 60 (2014), 590–598.
28. Xu, Y., Yu, H., Qin, H., Kang, J., Yu, C., Zhong, J., Su, J., Li, H., Sun, L., Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett. 314 (2012), 232–243.
29. Zhang, Y., Yang, W.Q., Zhu, H., Qian, Y.Y., Zhou, L., Ren, Y.J., Ren, X.C., Zhang, L., Liu, X.P., Liu, C.G., Ming, Z.J., Li, B., Chen, B., Wang, J.R., Liu, Y.B., Yang, J.M., Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin. Biochem. Pharmacol. 87 (2014), 562–570.
30. Zhu, H., Wu, H., Liu, X., Li, B., Chen, Y., Ren, X., Liu, C.G., Yang, J.M., Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 5 (2009), 816–823.